- Home
- NTWK vs GDTC Comparison
NTWK vs GDTC Comparison
Compare NTWK & GDTC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- NTWK
- GDTC
- Stock Information
- Founded
- NTWK 1997
- GDTC 2018
- Country
- NTWK United States
- GDTC Singapore
- Employees
- NTWK N/A
- GDTC N/A
- Industry
- NTWK Computer Software: Prepackaged Software
- GDTC Biotechnology: Pharmaceutical Preparations
- Sector
- NTWK Technology
- GDTC Health Care
- Exchange
- NTWK Nasdaq
- GDTC Nasdaq
- Market Cap
- NTWK 28.0M
- GDTC 28.0M
- IPO Year
- NTWK 1998
- GDTC 2023
- Fundamental
- Price
- NTWK $2.81
- GDTC $2.34
- Analyst Decision
- NTWK
- GDTC Buy
- Analyst Count
- NTWK 0
- GDTC 1
- Target Price
- NTWK N/A
- GDTC $5.00
- AVG Volume (30 Days)
- NTWK 18.4K
- GDTC 11.8K
- Earning Date
- NTWK 05-14-2025
- GDTC 01-01-0001
- Dividend Yield
- NTWK N/A
- GDTC N/A
- EPS Growth
- NTWK N/A
- GDTC N/A
- EPS
- NTWK N/A
- GDTC N/A
- Revenue
- NTWK $62,048,128.00
- GDTC $368,838.00
- Revenue This Year
- NTWK N/A
- GDTC N/A
- Revenue Next Year
- NTWK N/A
- GDTC N/A
- P/E Ratio
- NTWK N/A
- GDTC N/A
- Revenue Growth
- NTWK 9.28
- GDTC N/A
- 52 Week Low
- NTWK $2.14
- GDTC $1.20
- 52 Week High
- NTWK $3.34
- GDTC $4.05
- Technical
- Relative Strength Index (RSI)
- NTWK 71.62
- GDTC 45.58
- Support Level
- NTWK $2.34
- GDTC $2.21
- Resistance Level
- NTWK $2.48
- GDTC $2.60
- Average True Range (ATR)
- NTWK 0.10
- GDTC 0.13
- MACD
- NTWK 0.03
- GDTC -0.00
- Stochastic Oscillator
- NTWK 85.25
- GDTC 21.38
About NTWK NetSol Technologies Inc. Common Stock
NETSOL Technologies Inc is involved in providing information technology and enterprise software solutions. Its products and services include NFS Ascent, NFS Digital, Leasepak Cloud, Business consultancy, and information security services among others. The firm has North America, Europe, and Asia-Pacific segments, of which the majority of the revenue is derived from Asia-Pacific. It derives revenue from licensing, customization, enhancements, and maintenance of its financial applications. The company promotes and sells its products under the Netsol financial suite.
About GDTC CytoMed Therapeutics Limited
CytoMed Therapeutics Ltd is a pre-clinical biopharmaceutical company focused on harnessing its proprietary technologies to create novel cell-based immunotherapies for the treatment of human cancers. The development of its novel technologies has been inspired by the clinical success of existing CAR-T cells in treating hematological malignancies as well as the current clinical limitations and commercial challenges in extrapolating the CAR-T principle into the treatment of solid tumors. Geographically, the company operates in Singapore and Malaysia which is the majority revenue generator.